Sodium chloride or Plasmalyte-148 evaluation in severe diabetic ketoacidosis (SCOPE-DKA): a cluster, crossover, randomized, controlled trial.
Ramanan M, Attokaran A, Murray L, Bhadange N, Stewart D, Rajendran G, Pusapati R, Petty M, Garrett P, Kruger P, Peake S, Billot L, Venkatesh B; SCOPE-DKA Collaborators and Queensland Critical Care Research Network (QCCRN).
Ramanan M, et al.
Intensive Care Med. 2021 Nov;47(11):1248-1257. doi: 10.1007/s00134-021-06480-5. Epub 2021 Oct 5.
Intensive Care Med. 2021.
PMID: 34609547
Clinical Trial.